Product Information
DROSPIRENONE-EE 3-0.02 MG TAB is a generic product labeled by NorthStar Rx LLC, priced at $0.1895 per EA under NDC 72603087503. Its NADAC has been published 29 times since Feb 4, 2026.
FDA first approved this application on Feb 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
NorthStar Rx LLCNDC
72603087503
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA209632FDA Approved
2/27/2018
TE Code
AB
On Market Since
9/1/2025
Price Statistics
The NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has been published 29 times since Feb 4, 2026, and over the history we have for it it has risen 13.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1895 per EA |
|---|---|
| All-time high | $0.1933 (Aug 12, 2026) |
| All-time low | $0.1638 (Mar 18, 2026) |
| 52-week high | $0.1933 |
| 52-week low | $0.1638 |
| Median price | $0.1671 |
| Average price | $0.1762 |
| Largest weekly change | +8.5% (May 20, 2026) |
| Weeks tracked | 29 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DROSPIRENONE-EE 3-0.02 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DROSPIRENONE-EE 3-0.02 MG TAB, manufactured by NorthStar Rx LLC, is $0.1895 per EA (NDC 72603087503), effective Aug 19, 2026.
How has the price of DROSPIRENONE-EE 3-0.02 MG TAB changed over time?
Over the history we have for it, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has risen 13.4%. It has been tracked across 29 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for DROSPIRENONE-EE 3-0.02 MG TAB?
Since Feb 4, 2026, the NADAC for DROSPIRENONE-EE 3-0.02 MG TAB has ranged from a low of $0.1638 (Mar 18, 2026) to a high of $0.1933 (Aug 12, 2026), with a median of $0.1671 per EA.
Are there cheaper alternatives to DROSPIRENONE-EE 3-0.02 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZUMANDIMINE 3 MG-0.03 MG TAB, is $0.1492 per EA — about 21% below DROSPIRENONE-EE 3-0.02 MG TAB.
Who manufactures DROSPIRENONE-EE 3-0.02 MG TAB?
DROSPIRENONE-EE 3-0.02 MG TAB (NDC 72603087503) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.